Literature DB >> 8675184

Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis.

H Mizuhara1, M Uno, N Seki, M Yamashita, M Yamaoka, T Ogawa, K Kaneda, T Fujii, H Senoh, H Fujiwara.   

Abstract

A single intravenous injection of concanavalin A (Con A) induces T-cell activation and an acute hepatitis in mice. This study investigated the role of interferon gamma (IFN-gamma) in the pathogenesis of this hepatitis model. Striking increases in the plasma levels of various cytokines, including tumor necrosis factor (TNF), interleukin-2 (IL-2), and IFN-gamma, were detected before the increase in plasma aminotransferase levels induced by Con A injection. TNF levels peaked within 2 hours, whereas IFN-gamma levels peaked at 6 hours after Con A injection. In contrast to a sharp peak of TNF levels, high IFN-gamma levels were detected for a more prolonged period. Passive immunization with anti-IFN-gamma monoclonal antibody (MAb) conferred a dose-dependent protection against liver injury in this model. This protection was observed when anti-IFN-gamma MAb was administered at least 30 minutes before Con A injection but not when given 1 hour after Con A injection. The protection from Con A-induced hepatitis was also induced by administration of rIL-6 before Con A injection. rIL-6 treatment induced significant albeit incomplete inhibition of IFN-gamma and TNF production, whereas this regimen did not affect IL-2 production. Despite striking protective effects of rIL-6 or anti-IFN-gamma MAb, comparable levels of cellular (both T cell and polymorphonuclear cell) infiltration were detected in liver sections from animals untreated, or treated with either rIL-6 or anti-IFN-gamma MAb. Moreover, electron microscopic examination showed that infiltrating T cells exhibited a blastoid appearance in all groups. These results indicate that IFN-gamma plays a critical role in the development of Con A-induced acute hepatitis and suggest that IL-6 administration can regulate the manifestation of hepatitis through mechanisms including the reduced production of inflammatory cytokines such as IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8675184     DOI: 10.1053/jhep.1996.v23.pm0008675184

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  37 in total

Review 1.  Animal models of acute hepatic failure.

Authors:  T M Rahman; H J Hodgson
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

Review 2.  Regulatory mechanisms of antitumor T cell responses in the tumor-bearing state.

Authors:  H Fujiwara; T Hamaoka
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

3.  Preventive effects of 1,25-(OH)2VD3 against ConA-induced mouse hepatitis through promoting vitamin D receptor gene expression.

Authors:  Xu-dong Hu; Shi-li Jiang; Cheng-hai Liu; Yi-yang Hu; Cheng Liu; Ming-yu Sun; Gao-feng Chen; Ping Liu
Journal:  Acta Pharmacol Sin       Date:  2010-06       Impact factor: 6.150

4.  The ribavirin analog ICN 17261 demonstrates reduced toxicity and antiviral effects with retention of both immunomodulatory activity and reduction of hepatitis-induced serum alanine aminotransferase levels.

Authors:  R C Tam; K Ramasamy; J Bard; B Pai; C Lim; D R Averett
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

5.  Expression of a cyclo-oxygenase-2 transgene in murine liver causes hepatitis.

Authors:  Jun Yu; Alex Y Hui; Eagle S H Chu; Alfred S L Cheng; Minnie Y Y Go; Henry L Y Chan; Wai K Leung; Kin F Cheung; Arthur K K Ching; Yiu L Chui; Ka K Chan; Joseph J Y Sung
Journal:  Gut       Date:  2006-12-05       Impact factor: 23.059

6.  Role of monocytes and macrophages in experimental and human acute liver failure.

Authors:  Lucia A Possamai; Charalambos Gustav Antoniades; Quentin M Anstee; Alberto Quaglia; Diego Vergani; Mark Thursz; Julia Wendon
Journal:  World J Gastroenterol       Date:  2010-04-21       Impact factor: 5.742

7.  Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS.

Authors:  Feng Hong; Barbara Jaruga; Won Ho Kim; Svetlana Radaeva; Osama N El-Assal; Zhigang Tian; Van-Anh Nguyen; Bin Gao
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

8.  Contribution of gut bacteria to liver pathobiology.

Authors:  Gakuhei Son; Michael Kremer; Ian N Hines
Journal:  Gastroenterol Res Pract       Date:  2010-07-28       Impact factor: 2.260

9.  Critical role of hypoxia and A2A adenosine receptors in liver tissue-protecting physiological anti-inflammatory pathway.

Authors:  Alexander Choukèr; Manfred Thiel; Dmitriy Lukashev; Jerrold M Ward; Ines Kaufmann; Sergey Apasov; Michail V Sitkovsky; Akio Ohta
Journal:  Mol Med       Date:  2008 Mar-Apr       Impact factor: 6.354

10.  In vivo consequence of vitamin C insufficiency in liver injury: vitamin C ameliorates T-cell-mediated acute liver injury in gulo(-/-) mice.

Authors:  Seyeon Bae; Chung-Hyun Cho; Hyemin Kim; Yejin Kim; Hang-Rae Kim; Young-Il Hwang; Jung Hwan Yoon; Jae Seung Kang; Wang Jae Lee
Journal:  Antioxid Redox Signal       Date:  2013-04-18       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.